Key Highlights
- Rocket Lab shares advanced 11.3%, reaching an intraday peak of $123.94 following Needham’s price target increase from $95 to $120 with a maintained Buy recommendation.
- Cantor Fitzgerald increased its target to $96 from $85, highlighting improved launch performance and expanding space capabilities.
- First-quarter revenue reached $200.35 million, representing a 63.4% increase from the prior year and surpassing analyst estimates of $189.65 million.
- Loss per share of -$0.07 aligned with forecasts, while management upgraded Q2 projections.
- Wall Street’s consensus recommendation is “Moderate Buy” with an average target price of $91.79.
Rocket Lab USA (RKLB) experienced a significant rally on Monday, climbing 11.3% after Needham & Company increased its price objective from $95 to $120 while reaffirming its Buy recommendation.
Shares touched an intraday peak of $123.94 before consolidating near $117.35. Trading activity surged to approximately 53 million shares, exceeding twice the typical daily volume of 23.3 million.
The upward momentum followed an impressive first-quarter financial report. Rocket Lab delivered Q1 revenue of $200.35 million, exceeding Wall Street’s projection of $189.65 million and marking a 63.4% year-over-year increase.
The company’s loss per share stood at -$0.07, matching analyst expectations precisely. This compares favorably to the -$0.12 per share loss recorded in the same quarter last year, indicating substantial progress in narrowing losses.
Management’s decision to increase second-quarter guidance further bolstered investor confidence in the stock.
Wall Street Voices Support
Cantor Fitzgerald added to the positive sentiment, elevating its price objective to $96 from $85 while maintaining an Overweight stance. The firm highlighted Rocket Lab’s operational excellence in launches and its diverse service offerings, encompassing the Electron launch vehicle, the Haste hypersonic testing platform, and the forthcoming Neutron rocket program.
Stifel Nicolaus reaffirmed its Buy rating and increased its target from $90 to $105. Bank of America maintains a $120 target. Citigroup confirmed an Outperform rating last Friday.
While several analysts have issued bullish targets, the overall consensus average target stands at $91.79, notably below current trading levels. This discrepancy highlights the stock’s rapid appreciation.
Among analysts tracking RKLB, two assign Strong Buy ratings, ten recommend Buy, four maintain Hold positions, and one issues a Sell rating.
First Quarter Performance Analysis
Rocket Lab recorded a return on equity of -11.72% and a net margin of -26.87%, typical metrics for a high-growth aerospace company in expansion mode.
The first-quarter outperformance stemmed from robust activity across both launch operations and spacecraft systems divisions. Cantor emphasized the company’s dual launch facility infrastructure spanning New Zealand and the United States as a competitive differentiator.
Rocket Lab commands a market capitalization of approximately $66.82 billion, maintains a conservative debt-to-equity ratio of 0.02, and posts a current ratio of 4.47, indicating strong short-term financial flexibility.
The stock’s 50-day moving average sits at $72.88, while the 200-day average registers at $68.50, both considerably below present price levels.
Insider activity has trended toward selling. Over the past three months, company insiders divested approximately 233,449 shares totaling more than $16.4 million. SVP Arjun Kampani executed sales in early March at an average price of $69.59, while Director Merline Saintil sold shares at $75.04. Insiders collectively hold approximately 8.4% of outstanding shares, with institutional investors controlling 71.78%.
Wall Street anticipates a full-year loss of -$0.22 per share for the current fiscal period.
